Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant
| Autor: | Deepa R. J. Arachchillage, Martin Besser, Rhona Maclean, Trevor Baglin, Joost J. van Veen |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Rivaroxaban business.industry medicine.drug_class Anticoagulant Cancer Hematology 030204 cardiovascular system & hematology medicine.disease Thrombosis Gastroenterology Argatroban Dabigatran 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine Medicine Factor IIa Apixaban business medicine.drug |
| Zdroj: | Thrombosis Research. 143:137-140 |
| ISSN: | 0049-3848 |
| DOI: | 10.1016/j.thromres.2016.05.007 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect